Search clinical trials for: Sibutramine

Total 34 results

GlaxoSmithKline

Completed

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects

Obesity

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

Obesity
Abbott

Terminated

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Obesity | Weight Loss
Abbott

Completed

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients (SCOUT)

Obesity

United States
Abbott

Completed

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Obesity

United States
Mayo Clinic

Completed

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

Obesity | Overweight

United States
Abbott

Completed

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

Obesity | Binge Eating Disorder
Eisai Limited

Completed

A Comparative Study of KES524 in Patients With Obesity Disease

Obesity

Japan
Abbott

Completed

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

Obesity
Mayo Clinic
National Institutes of Health (NIH)

Completed

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

Obesity

United States
Promomed, LLC

Completed

Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

Obesity

Russian Federation
Pfizer

Completed

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Obesity

United States
Laboratorios Silanes S.A. de C.V.

Unknown

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Obesity

Mexico
Eurofarma Laboratorios S.A.

Not yet recruiting

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight (UNLIMITED)

Obesity | Overweight

Brazil
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Treatment of Binge Eating in Obese Patients in Primary Care

Obesity | Binge Eating

United States
Hippocration General Hospital

Completed

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS

Obesity | Polycystic Ovary Syndrome

Greece
Laval University

Completed

Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients

Hypertension | Obesity | Obstructive Sleep Apnea
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Obesity | Asthma | Weight Loss

Brazil
Brooke Army Medical Center
59th Medical Wing

Unknown

"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention" (AOS)

Obesity

United States
National Institute of Diabetes and Digestive and...

Completed

Adolescent Weight Management Study

Protocol #1:Behavioral Therapy + Placebo or Sibutramine | Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Obesity | Binge Eating

United States
University of Tennessee
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates (SUCCESS)

Heart Diseases | Cardiovascular Diseases | Obesity

United States
Inje University

Completed

Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects (sibu)

Healthy
New York State Psychiatric Institute
AstraZeneca

Terminated

Studying the Effects of Sibutramine on Eating Behavior

Obesity

United States
Pennington Biomedical Research Center
Louisiana Office of Group Benefits

Terminated

LOSS- Louisiana Obese Subjects Study (LOSS)

Obesity

United States
Abbott

Completed

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

Obesity
Nastech Pharmaceutical Company, Inc.

Completed

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

Obesity

United States
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Terminated

A Weight Loss Study in Overweight Men and Women

Obesity

United States
AstraZeneca

Completed

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Obesity | Overweight

United States
Gachon University Gil Medical Center

Completed

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

Obesity

Korea, Republic of
Wellspect HealthCare

Completed

Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization

Bacteriuria

United Kingdom
Aristotle University Of Thessaloniki

Unknown

The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)

Obesity | Polycystic Ovaries Syndrome

Greece
Abbott

Completed

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives (HOS)

Hypertension | Obesity

3

Subscribe